Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2284720Generated: November 1, 2026

Ethyl Acetate → Diethyl 2-(4-(2-((3-fluorophenyl)amino)-4-(propylamino)pyrimidin-5-yl)-2-methyl-3-butyn-2-yl)malonate

https://huagongshe.com/reaction/2284720

Reaction equation

Participants

RoleNameHCIDCharge
ReactantEthyl AcetateHCID 8857—
ReactantAmmonium ChlorideHCID 25517—
ReactantDiethyl (2-methylbut-3-yn-2-yl)propanedioateHCID 304028—
ReactantHCID 90051756HCID 90051756—
CatalystCopper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)HCID 24350—
CatalystHCID 178418397HCID 178418397—
CatalystHCID 178418476HCID 178418476—
SolventDimethylformamideHCID 6228—
SolventTriethylamineHCID 8471—
ProductDiethyl 2-(4-(2-((3-fluorophenyl)amino)-4-(propylamino)pyrimidin-5-yl)-2-methyl-3-butyn-2-yl)malonateHCID 90052124—

Reaction Steps

To a solution of diethyl 2-(2-methyl-3-butyn-2-yl)malonate synthesized according to the method described in Chemistry A European Journal, 2005, 11, pp. 308-320 (3.3 g), N2-(3-fluorophenyl)-5-iodo-N4-propylpyrimidine-2,4-diamine (F2, 868 mg), bis(triphenylphosphine)palladium(II) dichloride (161 mg) and copper(I) iodide (88 mg) in N,N-dimethylformamide (15 mL), triethylamine (1.6 mL) was added at room temperature, and the mixture was stirred at the same temperature for 2 hours and 30 minutes. To the reaction mixture, tetrakis(triphenylphosphine)palladium(0) (132 mg) was added at room temperature, and the mixture was stirred at the same temperature for 1 hour and 40 minutes. To the reaction mixture, ethyl acetate and saturated aqueous ammonium chloride were added. The organic layer was separated, washed successively with saturated aqueous ammonium chloride, water and saturated aqueous sodium chloride, and then dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography (eluent, 94 to 64% hexane in ethyl acetate) to obtain diethyl 2-(4-(2-((3-fluorophenyl)amino)-4-(propylamino)pyrimidin-5-yl)-2-methyl-3-butyn-2-yl)malonate (F13, 803 mg) as yellow solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09145415B2
Source datasetuspto-grants-2015_09
ORD IDord-45eab6484675405c9473792c09e0cc15
Source noteuspto-grants-2015_09